Soligenix, Inc. (SNGX) Dr. Chris Schaber Ph.D., CEO

Soligenix, Inc. is a late-stage biopharmaceutical company focusedon developing and commercializing products to treat rare disease where there isan unmet medical need.They have two areas of focus: a specializedbiotherapeutics segment dedicated to the development of products for orphandiseases and areas of unmet medical need such as cutaneous T-cell lymphoma,oral mucositis, pediatric Crohn’s disease, and psoriasis. Also, apublic health solutions segment to develop vaccines and therapeuticsfor military and civilian applications in the areas of ricin exposure, emergingand antibiotic resistant infectious disease, and viral disease including Ebola,Marburg and COVID-19.